 Veru Inc NASDAQ: VERU has submitted an emergency use authorization EUA for sabizabulin application to FDA for COVID-19 treatment. The application covers moderate to severe hospitalized COVID-19 patients at high risk for developing Acute Respiratory Distress Syndrome ARDS. 